market. Moreover, increasing research and development expenditure by biopharmaceutical
industries and biotechnology industries fosters growth of the cell lysis market. According to
2012 EU Industrial R&D Investment Scoreboard, the pharmaceutical and biotechnology sector
represented 17.7% of business R&D expenditure globally. However, high cost of cell based
research, owing to high expenditure in research and development for CAR-T cell therapy
hampers growth of the cell lysis market.
Report includes chapters which deeply display the following deliverable about industry:
• Cell Lysis Market Research Objective and Assumption
• Cell Lysis Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Cell Lysis Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Cell Lysis Market, By Regions
• Cell Lysis Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Cell Lysis Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Cell Lysis Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers
of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Cell Lysis Market Forecast including Production, Consumption, Import and Export Forecast by
Type, Applications and Region.
• Research Findings and Conclusion
Key companies covered as a part of this study include Becton, Dickinson and Company, Bio-
Rad Laboratories Inc., Cell Signaling Technology Inc., Thermo Fisher Scientific, Qiagen N.V.,
Qsonica, Merck KGaA, and F. Hoffman-La Roche Ltd..